Shopping Cart
- Remove All
![TargetMol](https://newstatic.targetmol.com/error/oops.webp)
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $143 | 35 days | |
5 mg | $668 | 35 days | |
10 mg | $1,260 | 35 days |
Description | NPD-2975 (compound 30) is an orally active antitrypanosomal agent effective against Human African Trypanosomiasis (HAT), demonstrating acceptable metabolic stability and low toxicity potential in human MRC-5 lung fibroblasts, as well as in an acute mouse model of T. b. brucei infection. It inhibits T. b. brucei with an in vitro IC50 of 70 nM and yields IC50 values of 0.16 μM and 0.42 μM against CYP1A2 and CYP2C19 enzymes, respectively [1]. |
In vivo | NPD-2975 administered orally (25 mg/kg, twice daily for five consecutive days; gavage) enhanced survival rates during the initial phase in a murine model of HAT infection [1]. Pharmacokinetic analysis of NPD-2975 in mice [1] revealed the following parameters for the oral (PO) and intraperitoneal (IP) routes: PO—Dose: 50 mg/kg, T_max: 1 h, C_max: 5.25 μM, T_1/2: 3.46 h, AUC_0-6 h: 6064.75 ng·h/mL, Cl: 58.5 mL/min; IP—Dose: 10 mg/kg, T_max: 13.18 h, C_max: 1.06 μM, T_1/2: 3928.37 h, AUC_0-6 h: 171 ng·h/mL. |
Molecular Weight | 272.28 |
Formula | C14H13FN4O |
Cas No. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.